Arteris (NASDAQ:AIP) Upgraded at Wall Street Zen

Arteris (NASDAQ:AIP) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

A number of other analysts have also recently issued reports on the company. Rosenblatt Securities reissued a “buy” rating and set a $14.00 price objective on shares of Arteris in a report on Wednesday, May 21st. TD Cowen increased their price objective on Arteris from $12.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Arteris has a consensus rating of “Buy” and an average target price of $15.00.

Arteris Price Performance

Shares of NASDAQ AIP opened at $9.42 on Friday. Arteris has a one year low of $5.46 and a one year high of $14.29. The business’s fifty day moving average price is $9.55 and its 200-day moving average price is $8.27. The stock has a market capitalization of $401.76 million, a PE ratio of -11.49 and a beta of 1.45.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, meeting analysts’ consensus estimates of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to analysts’ expectations of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts expect that Arteris will post -0.73 EPS for the current fiscal year.

Insiders Place Their Bets

In other Arteris news, Director Saiyed Atiq Raza sold 63,118 shares of the company’s stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.07, for a total value of $824,952.26. Following the transaction, the director directly owned 590,000 shares in the company, valued at $7,711,300. This represents a 9.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of the company’s stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.12, for a total value of $656,000.00. Following the completion of the transaction, the insider owned 9,839,071 shares in the company, valued at $129,088,611.52. This represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 456,043 shares of company stock worth $5,484,028. 29.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Arteris

Several institutional investors have recently modified their holdings of AIP. Raymond James Financial Inc. bought a new position in shares of Arteris during the 2nd quarter valued at about $32,000. Quarry LP bought a new position in shares of Arteris during the 4th quarter valued at about $46,000. CWM LLC increased its position in shares of Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock valued at $71,000 after purchasing an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. bought a new position in shares of Arteris during the 1st quarter valued at about $95,000. Finally, Savant Capital LLC bought a new position in shares of Arteris during the 2nd quarter valued at about $97,000. 64.36% of the stock is currently owned by institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.